Some days 50-year-old David Palmer can barely get out of bed and walk to the bathroom as his heart is so badly damaged. Now the father-of-two is hoping a revolutionary new treatment will come to his rescue.
The former IT consultant is taking part in a ground-breaking trial for a new gene therapy that aims to tackle heart failure. It involves injecting a gene which could stimulate heart cells into producing a vital protein called SERCA2a.
Research shows this protein has the capacity to repair worn-out heart muscle cells.
Share this article
The breakthrough treatment could bring new hope to those who no longer respond well to other treatments and may be too ill to undergo a heart transplant.
Read the full, original story here: Gene therapy trial: The virus that could help damaged hearts
